Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rabe

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Plos One|December 23, 2021
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric CancerManish A Shah, Zev A Wainberg, Daniel V T Catenacci, et al.
Plos One|October 10, 2022
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric CancerManish A Shah, Zev A Wainberg, Daniel V T Catenacci, et al.
Nature|March 8, 2019
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolismJiyoung Lee, Ali E Yesilkanal, Joseph P Wynne, et al.
The Journal of Clinical Investigation|June 16, 2022
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotypeRebecca L Porter, Siyu Sun, Micayla N Flores, et al.
Science Advances|January 10, 2025
Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity captureDaniel C Rabe, Adarsh Choudhury, Dasol Lee, et al.
Annals of the New York Academy of Sciences|March 24, 2023
Exosomes, microvesicles, and other extracellular vesicles-a Keystone Symposia reportJennifer Cable, Kenneth W Witwer, Robert J Coffey, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Plos One|December 23, 2021
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric CancerManish A Shah, Zev A Wainberg, Daniel V T Catenacci, et al.
Plos One|October 10, 2022
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric CancerManish A Shah, Zev A Wainberg, Daniel V T Catenacci, et al.
Nature|March 8, 2019
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolismJiyoung Lee, Ali E Yesilkanal, Joseph P Wynne, et al.
The Journal of Clinical Investigation|June 16, 2022
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotypeRebecca L Porter, Siyu Sun, Micayla N Flores, et al.
Science Advances|January 10, 2025
Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity captureDaniel C Rabe, Adarsh Choudhury, Dasol Lee, et al.
Annals of the New York Academy of Sciences|March 24, 2023
Exosomes, microvesicles, and other extracellular vesicles-a Keystone Symposia reportJennifer Cable, Kenneth W Witwer, Robert J Coffey, et al.
Pageof 6